Patents by Inventor Christopher Robb

Christopher Robb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for making alpha-substituted hydroxamic acids
    Publication number: 20050043533
    Abstract: This invention is directed generally to a process for making ?-substituted hydroxamic acids (including salts thereof) generally corresponding in structure to Formula (I): wherein n, Z, Z3, A, R, E, and Y are as defined in this patent. This invention also is directed to compounds that may, for example, be used as intermediates in such a process, as well as processes for making such compounds.
    Type: Application
    Filed: March 24, 2004
    Publication date: February 24, 2005
    Inventors: Kevin Babiak, Terri Boehm, Pierre-Jean Colson, Payman Farid, Donald Gallagher, Christian Huber, Russell Linderman, Chin Liu, Eduardo Mar, Murad Newaz, Daniel Pippel, Claire Przybyla, Christopher Robb, Glenn Stahl, Ravindra Topgi, Gerald Weisenburger, Edward Yonan
  • Non-antibiotic system for selection of recombinant mycobacteria
    Patent number: 5895756
    Abstract: The present invention provides a Mycobacterium-E. coli shuttle vector containing sequences coding for a tribrid fusion containing the M. leprae 18kDa antigen sequence, a phoA protein antigen sequence and a non-mycobacterial, non-E.coli heterologous protein antigen sequence. Also provided is a method of producing protective immunity in an animal or human host in need of such treatment, comprising the step of administering to said animal or human host an effective dose of recombinant mycobacteria carrying the vector of the present invention.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: April 20, 1999
    Assignee: The Board of Trustees of the University of Texas System
    Inventors: Alan D. T. Barrett, David Niesel, Christopher Robb, Haolin Ni